Striving to expand patient access to Guardant Health’s cancer tests, Andreas currently serves as General Manager of Guardant Health Japan. He is responsible for Japan’s operations and customer support initiatives. Prior to leading Guardant Health Japan, he drove and supported expansion of Guardant Health into Japan as a consultant, where Andreas and the team collaborated with early adopting KOLs and Cancer Centers.
Before joining Guardant Health, he led Thermo Fisher Scientific’s Global Clinical NGS as Vice President, Diagnostic Partnering & Strategic Accounts. He started up and was President of Thermo Fisher Diagnostic K.K. prior to the global appointment. Andreas has worked in the oncology field, having launched cancer drugs in Japan for Merck KGaA, and being responsible for pharma operations in the US, Japan and Europe. Andreas holds a BS in Biology from the University of York, UK, and an MBA from Middlebury College at Monterey in the US.